Noriyuki Morikawa
Tsukuba, 3058585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Pharmacological characterization of AS2690168, a novel small molecule RANKL signal transduction inhibitor.
Journal: European journal of pharmacology
Published: October 19, 2021
High non-relapse mortality and low relapse incidence in gender-mismatched allogeneic hematopoietic stem cell transplantation from a parous female donor with a male child.
Journal: Leukemia & lymphoma
Published: November 29, 2016
Characteristics and outcomes of patients diagnosed with norovirus gastroenteritis after allogeneic hematopoietic stem cell transplantation based on immunochromatography.
Journal: International journal of hematology
Published: February 13, 2015
Incidental detection of malignant lymphoma in subjects in a cancer surveillance programme.
Journal: British journal of haematology
Published: October 11, 2014
Pulmonary Nocardia nova infection after allogeneic hematopoietic stem cell transplantation.
Journal: Internal medicine (Tokyo, Japan)
Published: June 17, 2014
Follow-up data of 10 patients with B-cell non-Hodgkin lymphoma with a CD20-negative phenotypic change after rituximab-containing therapy.
Journal: The American journal of surgical pathology
Published: February 22, 2013
Bcl-2, Bcl-6, and the International Prognostic Index are prognostic indicators in patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Journal: Cancer science
Published: June 10, 2012
Orally available pyridinylpyrimidine derivatives as novel RANKL-induced osteoclastogenesis inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: May 22, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026